WARNINGS
Do not exceed the recommended dose and duration of treatment. Special precautions for use in animals: none. Special precautions to be taken by the person administering the veterinary medicine to the animals: none. Do not exceed the indicated doses and duration. The product has a high safety margin. The toxicity of Toldimfos is very low. Acute toxicity via intravenous route is between 5000 and 6000 mg/Kg. Vitamin B1 via intravenous route has an acute toxicity of 300 mg/Kg in dogs. The maximum dose used in this species with the administration of Stimulfos Tablets is 5 mg/Kg. The B vitamins contained in Stimulfos Tablets do not present particularly high individual concentrations and are those normally used in supportive therapies. Incompatibilities: not relevant.
PHARMACOTHERAPEUTIC CATEGORY
Other mineral supplements.
STORAGE
Do not store at temperatures above 25 degrees C. After each use, close the bottle to protect the medicine from light and moisture. Shelf life of the veterinary medicine packaged for sale: 3 years. Shelf life after first opening of the primary packaging: 25 days.
CONTRAINDICATIONS/ADVERSE EFFECTS
Hypersensitivity to the active ingredients or any of the excipients listed.
NAME
STIMULFOS TABLETS FOR DOGS AND CATS
DIAGNOSIS AND PRESCRIPTION
Sale is not subject to veterinary prescription requirement.
EXCIPIENTS
Corn starch, rice starch, gum arabic, lactose monohydrate, magnesium stearate, mono- and di-glycerides of edible fatty acids, polyvinylpyrrolidone, talc.
ADVERSE EFFECTS
None noted.
PREGNANCY AND LACTATION
The medicine can be used during pregnancy and lactation.
INDICATIONS
Deficiencies of B vitamins and their various clinical forms, paresis and tetany, asthenia, convalescence, stress and intense muscular work, anemias.
INTERACTIONS
None known.
DOSAGE
For oral use. Stress and intense muscular work, paresis and tetany: depending on the clinical picture and at the discretion of the Veterinarian, administer one tablet for every 4 Kg of weight or one tablet for every 8 Kg of weight once a day for ten days. As a B vitamin complex: one tablet for every 20 Kg of weight once a day for ten days. Anemias and convalescence: one tablet for every 8 Kg of weight once a day for ten days. The tablet has a cross incision to allow division in half or quarters. Place the tablet on a flat surface with the fracture lines facing up. Apply pressure with the thumb at the center of the tablet to achieve division into 4 quarters.
ACTIVE INGREDIENTS
One tablet contains: active ingredients: toldimfos (sodium salt) (equivalent to acid 40 mg) 44.5 mg; thiamine mononitrate (Vitamin B1) 20 mg; riboflavin (Vitamin B2) 2 mg; pyridoxine hydrochloride (Vitamin B6) 1 mg; cyanocobalamin (Vitamin B12) 8 mcg; nicotinamide (Vitamin PP) 20 mg; calcium pantothenate 4 mg. Excipients: for the complete list of excipients, see paragraph 6.1.
SAFETY IN TARGET SPECIES
Do not exceed the indicated doses and duration. The product has a high safety margin. The toxicity of Toldimfos is very low. Acute toxicity via intravenous route is between 5000 and 6000 mg/Kg. Vitamin B1 via intravenous route has an acute toxicity of 300 mg/Kg in dogs. The maximum dose used in this species with the administration of Stimulfos Tablets is 5 mg/Kg. The B vitamins contained in Stimulfos Tablets do not present particularly high individual concentrations and are those normally used in supportive therapies.
TARGET SPECIES
Dogs and cats.
WITHDRAWAL TIME
Not relevant.
ADMINISTRATION/ROUTE OF ADMINISTRATION
For oral use.